Robert C. Smart - Raleigh NC Hye-Sun Oh - Raleigh NC
Assignee:
North Carolina State University - Raleigh NC
International Classification:
A61K 3156
US Classification:
514182, 514324, 514422, 514651, 514880
Abstract:
A method of enhancing hair growth or treating alopecia in a subject uses topically administered estrogen receptor antagonists. Pharmaceutical formulations comprising estrogen receptor antagonists are described.
Ccaat/Enhancer Binding Protein-Beta (C/Ebpbeta) Is A Molecular Target For Cancer Treatment
Robert Smart - Raleigh NC, US Songyun Zhu - Durham NC, US Peter Johnson - Frederick MD, US G. Sterneck - Frederick MD, US
International Classification:
A61K048/00 C12Q001/68 G01N033/574 A61K039/395
US Classification:
514/044000, 424/155100, 435/006000, 435/007230
Abstract:
A method of inhibiting C/EBP activity in a cell is carried out by treating the cell with a compound that disrupts the C/EBP signaling pathway. Methods of identifying compounds useful for carrying out such treatments are also described.
Robert Smart - Raleigh NC, US Hye-Sun Oh - Raleigh NC, US
International Classification:
A61K031/56 A61K031/58
US Classification:
514/169000, 514/176000, 514/182000
Abstract:
A method of enhancing hair growth or treating alopecia in a subject uses topically administered estrogen receptor antagonists. Pharmaceutical formulations comprising estrogen receptor antagonists are described.
Robert C. Smart - Raleigh NC Hye-Sun Oh - Raleigh NC
Assignee:
North Carolina State University - Raleigh NC
International Classification:
A61K 3156
US Classification:
514178
Abstract:
A method of enhancing hair growth or treating alopecia in a subject uses topically administered estrogen receptor antagonists. Pharmaceutical formulations comprising estrogen receptor antagonists are described.
Robert C. Smart - Raleigh NC Hye-Sun Oh - Raleigh NC
Assignee:
North Carolina State University - Raleigh NC
International Classification:
A61K 100
US Classification:
514182
Abstract:
A method of enhancing hair growth or treating alopecia in a subject uses topically administered estrogen receptor antagonists. Pharmaceutical formulations comprising estrogen receptor antagonists are described.
Orange County, CaliforniaChief Financial Officer at Hanover Financial Compa... Past: VP Finance at Hon Development Company, Consulting Manager at Kenneth Leventhal & Company...